血液透析患者导管相关血流感染:COVID-19大流行前后的进展
研究利用美国肾脏数据系统数据,分析2018年3月至2020年11月透析中心抗生素使用率和导管相关血流感染住院率。大流行前6个月,抗生素使用率较2019年同期降低20%至21%,导管相关血流感染住院率降低17%至24%,脓毒症住院率无显著变化。2018至2019年导管相关事件亦下降,主要由大型透析提供者运营的中心驱动。
要点
- 大流行前6个月抗生素使用率较2019年同期降低20%至21%。
- 导管相关血流感染住院率较2019年同期降低17%至24%。
- 脓毒症住院率无显著变化。
核心结论
- 大流行期间导管相关感染显著减少,叠加于大流行前部分中心非大流行相关的下降之上。
- 作者认为即使大流行后,继续部分COVID-19缓解措施以预防导管相关血流感染可能是审慎的。
研究设计与样本
- 利用美国肾脏数据系统数据,分析2018年3月至2020年11月透析中心抗生素使用率和导管相关血流感染住院率,以及脓毒症住院率。
- 采用逻辑回归估计3个月间隔的逐年调整比值比。
主要发现
- 大流行前6个月,抗生素使用率较2019年同期降低20%至21%。
- 大流行前6个月,导管相关血流感染住院率较2019年同期降低17%至24%。
- 脓毒症住院率无显著变化。
- 2018至2019年间导管相关事件亦下降,由大型透析提供者运营的中心减少驱动。
临床怎么用
- 作者认为即使大流行后,继续部分COVID-19缓解措施以预防导管相关血流感染可能是审慎的。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measures implemented to prevent transmission of severe acute respiratory syndrome coronavirus 2 in outpatient dialysis facilities may also help to prevent catheter-associated bloodstream infections in patients receiving hemodialysis. We used United States Renal Data System data to examine rates of antibiotic administration within dialysis facilities and rates of hospital admission for catheter-associated bloodstream infection from March 2018 through November 2020, and rates of hospitalization for sepsis, to address overall changes in hospitalization during the coronavirus disease 2019 (COVID-19) pandemic. Using logistic regression, we estimated year-over-year adjusted odds ratios of these events in 3-month intervals. During the first 6 months of the pandemic, rates of antibiotic administration were between 20% and 21% lower, and rates of hospitalization for catheter-associated bloodstream infection were between 17% and 24% lower than during corresponding periods in 2019, without significant changes in rates of hospitalization for sepsis. However, rates of catheter-associated events also decreased between 2018 and 2019, driven by reductions in facilities operated by a large dialysis provider. These data suggest that significant reductions in catheter-associated infections occurred during the pandemic, superimposed on nonpandemic-related reductions in some facilities before the pandemic. Even after the pandemic, it may be prudent to continue some COVID-19 mitigation measures to prevent catheter-associated bloodstream infections.
引用
- Johansen KL, Gilbertson DT, Wetmore JB, et al. Catheter-Associated Bloodstream Infections among Patients on Hemodialysis: Progress before and during the COVID-19 Pandemic. Clin J Am Soc Nephrol. 2022. PMID: 35110377. doi:10.2215/CJN.11360821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。